Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S L Smith

Showing results (331-340 of 348) with videos related to

Pageof 35
Sort By:
Acta Astronautica|September 7, 2001
Adaptation of neuromuscular activation patterns during treadmill walking after long-duration space flightC S Layne, G W Lange, C J Pruett, et al.
Antimicrobial Agents and Chemotherapy|October 23, 1997
In vivo antiviral activity and pharmacokinetics of (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in woodchuck hepatitis virus-infected woodchucksJ M Cullen, S L Smith, M G Davis, et al.
Public Health Action|December 5, 2017
Closing the gap: decentralising mental health care to primary care centres in one rural district of RwandaB Nyirandagijimana, J K Edwards, E Venables, et al.
Cytometry|March 1, 1996
Immunocytochemistry and flow cytometry evaluation of human megakaryocytes in fresh samples and cultures of CD34+ cellsX Qiao, M Loudovaris, K Unverzagt, et al.
Anesthesiology|October 1, 1995
Effects of perioperative analgesic technique on rate of recovery after colon surgeryS S Liu, R L Carpenter, D C Mackey, et al.
Antimicrobial Agents and Chemotherapy|August 3, 1999
Acyclovir is phosphorylated by the human cytomegalovirus UL97 proteinC L Talarico, T C Burnette, W H Miller, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1991
U-78517F: a potent inhibitor of lipid peroxidation with activity in experimental brain injury and ischemiaE D Hall, J M Braughler, P A Yonkers, et al.
Journal of Hematotherapy|June 1, 1996
Large-scale selection of CD34+ peripheral blood progenitors and expansion of neutrophil precursors for clinical applicationsT M Zimmerman, J G Bender, W J Lee, et al.
Breast Cancer Research and Treatment|November 27, 2013
CD44 is prognostic for overall survival in the NCI randomized trial on breast conservation with 25 year follow-upT Dan, S M Hewitt, N Ohri, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1997
Pyrrolopyrimidines: novel brain-penetrating antioxidants with neuroprotective activity in brain injury and ischemia modelsE D Hall, P K Andrus, S L Smith, et al.
Pageof 35

Showing results (331-340 of 348) with videos related to

Sort By:
Pageof 35
Acta Astronautica|September 7, 2001
Adaptation of neuromuscular activation patterns during treadmill walking after long-duration space flightC S Layne, G W Lange, C J Pruett, et al.
Antimicrobial Agents and Chemotherapy|October 23, 1997
In vivo antiviral activity and pharmacokinetics of (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in woodchuck hepatitis virus-infected woodchucksJ M Cullen, S L Smith, M G Davis, et al.
Public Health Action|December 5, 2017
Closing the gap: decentralising mental health care to primary care centres in one rural district of RwandaB Nyirandagijimana, J K Edwards, E Venables, et al.
Cytometry|March 1, 1996
Immunocytochemistry and flow cytometry evaluation of human megakaryocytes in fresh samples and cultures of CD34+ cellsX Qiao, M Loudovaris, K Unverzagt, et al.
Anesthesiology|October 1, 1995
Effects of perioperative analgesic technique on rate of recovery after colon surgeryS S Liu, R L Carpenter, D C Mackey, et al.
Antimicrobial Agents and Chemotherapy|August 3, 1999
Acyclovir is phosphorylated by the human cytomegalovirus UL97 proteinC L Talarico, T C Burnette, W H Miller, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1991
U-78517F: a potent inhibitor of lipid peroxidation with activity in experimental brain injury and ischemiaE D Hall, J M Braughler, P A Yonkers, et al.
Journal of Hematotherapy|June 1, 1996
Large-scale selection of CD34+ peripheral blood progenitors and expansion of neutrophil precursors for clinical applicationsT M Zimmerman, J G Bender, W J Lee, et al.
Breast Cancer Research and Treatment|November 27, 2013
CD44 is prognostic for overall survival in the NCI randomized trial on breast conservation with 25 year follow-upT Dan, S M Hewitt, N Ohri, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1997
Pyrrolopyrimidines: novel brain-penetrating antioxidants with neuroprotective activity in brain injury and ischemia modelsE D Hall, P K Andrus, S L Smith, et al.
Pageof 35